Screener
Kura Oncology KURA EBITDA margin
EBITDA margin at other companies
Other financials
Where this comes from
Calculated from Kura Oncology’s reported figures.
Based on trailing twelve months.
The source filing: Kura Oncology’s 10-Q, filed May 12, 2026. Open the filing →
- Filed
- May 12, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-219481
FAQ
- What is Kura Oncology's EBITDA margin?
- Kura Oncology (KURA) reported EBITDA margin of -441.9% in Q1 2026.
- How has Kura Oncology's EBITDA margin changed year-over-year?
- Kura Oncology's EBITDA margin decreased by 18.9% year-over-year, from -371.6% to -441.9%.
- What does EBITDA margin mean?
- EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.
Ask your AI about Kura Oncology's ebitda margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude